Anticoagulants Market to Witness Huge Growth by 2026

Anticoagulants Market Anticoagulants Market Segmentation by Route of Administration - Oral, Injectables; Drug Class - Factor XA Inhibitors, Heparins, Direct Thrombin Inhibitors, Vitamin K Antagonists; Indication - Deep Vein Thrombosis, Pulmonary Embolism, Atrial Fibrillation and Heart Attack; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Forecast 2018 - 2026

Š2019 Transparency Market Research, All Rights Reserved

Table of Content

Sr. No.

Content

Chapter1

Preface

Chapter 2

Assumptions and Research Methodology

Chapter 3

Executive Summary: Global Anticoagulants Market

Chapter 4

Market Overview

Chapter 5

Global Anticoagulants Market Analysis and Forecast, by Route of Administration

Chapter 6

Global Anticoagulants Market Analysis and Forecast, by Drug Class

Chapter 7

Global Anticoagulants Market Analysis and Forecast, by Indication

Chapter 8

Global Anticoagulants Market Analysis and Forecast, by Distribution Channel

Chapter 9

Global Anticoagulants Market Analysis and Forecast, by Region

Chapter 10

North America Anticoagulants Market Analysis and Forecast

Chapter 11

Europe Anticoagulants Market Analysis and Forecast

Chapter 12

Asia Pacific Anticoagulants Market Analysis and Forecast

Chapter 13

Latin America Anticoagulants Market Analysis and Forecast

Chapter 14

Middle East & Africa Anticoagulants Market Analysis and Forecast

Chapter 15

Competitive Landscape Š2019 Transparency Market Research, All Rights Reserved

Anticoagulants Market - Snapshot

l

l

l

Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins.

Heparins, including unfractionated heparin (UFH) and low molecular weight heparin; vitamin K antagonists, DTIs, and factor Xa inhibitors, are the various anticoagulants available in the market.

According to the report, the global anticoagulants market is projected to expand at a CAGR of 8.0% from 2018 to 2026.

Š2019 Transparency Market Research, All Rights Reserved

Reports Highlights

•

•

•

Rise in prevalence of obesity, increase in hip and knee surgeries, and surge in cases of coagulation disorders are anticipated to boost the growth of the global Anticoagulants market from 2018 to 2026.

Dwindling birth rates have led to an increase in the geriatric population.

Rise in standard of health care facilities and availability of advanced treatment options boost life expectancy rates across the world.

Request For Sample ©2019 Transparency Market Research, All Rights Reserved

Continue.. l

l

l

The rise in adoption of Novel Oral Anticoagulants (NOACs) boosts market growth. NOACs target either factor Xa to avoid or to treat thrombosis.

According to CDC 2016 report, over a million people in the U.S. undergo hip and knee replacement surgeries.

Key players operating in the global anticoagulants market include Bayer Healthcare, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company.

Request For Brochure

Š2019 Transparency Market Research, All Rights Reserved

Contact

To know more about us, please visit our website:

www.transparencymarketresearch.com For sales queries or new topics email us on:

sales@transparencymarketresearch.com

Thank You Š2019 Transparency Market Research, All Rights Reserved